[go: up one dir, main page]

DK3934624T3 - Topisk sammensætning og fremgangsmåder til måling af en topisk sammensætnings køleevne - Google Patents

Topisk sammensætning og fremgangsmåder til måling af en topisk sammensætnings køleevne Download PDF

Info

Publication number
DK3934624T3
DK3934624T3 DK20800255.0T DK20800255T DK3934624T3 DK 3934624 T3 DK3934624 T3 DK 3934624T3 DK 20800255 T DK20800255 T DK 20800255T DK 3934624 T3 DK3934624 T3 DK 3934624T3
Authority
DK
Denmark
Prior art keywords
topical composition
measuring
methods
cooling capacity
topical
Prior art date
Application number
DK20800255.0T
Other languages
English (en)
Inventor
Kenneth William James
James Andrew Provost
Original Assignee
Futura Medical Developments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73040144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3934624(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB1918039.7A external-priority patent/GB201918039D0/en
Priority claimed from GBGB2015404.3A external-priority patent/GB202015404D0/en
Application filed by Futura Medical Developments Ltd filed Critical Futura Medical Developments Ltd
Application granted granted Critical
Publication of DK3934624T3 publication Critical patent/DK3934624T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/417Imidazole-alkylamines, e.g. histamine, phentolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00Investigating or analyzing materials by the use of thermal means
    • G01N25/20Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
    • G01N25/48Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
    • G01N25/4846Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00Investigating or analyzing materials by the use of thermal means
    • G01N25/56Investigating or analyzing materials by the use of thermal means by investigating moisture content
    • G01N25/58Investigating or analyzing materials by the use of thermal means by investigating moisture content by measuring changes of properties of the material due to heat, cold or expansion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Combustion & Propulsion (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK20800255.0T 2019-12-09 2020-10-22 Topisk sammensætning og fremgangsmåder til måling af en topisk sammensætnings køleevne DK3934624T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1918039.7A GB201918039D0 (en) 2019-12-09 2019-12-09 Topical composition
GBGB2015404.3A GB202015404D0 (en) 2020-09-29 2020-09-29 Topical composition
PCT/GB2020/052660 WO2021116651A1 (en) 2019-12-09 2020-10-22 Topical composition and methods of measuring the cooling abaility of a topical composition

Publications (1)

Publication Number Publication Date
DK3934624T3 true DK3934624T3 (da) 2024-06-10

Family

ID=73040144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20800255.0T DK3934624T3 (da) 2019-12-09 2020-10-22 Topisk sammensætning og fremgangsmåder til måling af en topisk sammensætnings køleevne

Country Status (15)

Country Link
US (1) US20230022570A1 (da)
EP (2) EP3934624B1 (da)
KR (1) KR20220124712A (da)
CN (1) CN115003278A (da)
AU (1) AU2020401440A1 (da)
BR (1) BR112022011284A2 (da)
CA (1) CA3160206A1 (da)
DK (1) DK3934624T3 (da)
ES (1) ES2978421T3 (da)
FI (1) FI3934624T3 (da)
MX (1) MX2022007009A (da)
PL (1) PL3934624T3 (da)
PT (1) PT3934624T (da)
TW (1) TW202135785A (da)
WO (1) WO2021116651A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119112770A (zh) * 2023-12-27 2024-12-13 江苏澳德智科医疗科技有限公司 一种功能凝胶的制备方法
CN118576540A (zh) * 2024-07-30 2024-09-03 杭州启真求实科技有限公司 一种用于男性勃起障碍外用的组合物凝胶及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2716739B2 (ja) * 1988-07-26 1998-02-18 インデナ エス.ピー.エイ 血管運動作用を有する化粧用組成物
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6435710B1 (en) * 1998-08-26 2002-08-20 Fauske & Associates, Inc. Foam detector apparatus and method
GB0602224D0 (en) * 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
RU2342923C1 (ru) * 2007-07-26 2009-01-10 Общество с ограниченной ответственностью "Бентус лаборатории" Дезинфицирующее антисептическое средство для обработки рук с увлажняющим эффектом (варианты)
US20090318510A1 (en) * 2008-06-24 2009-12-24 Glycobiosciences, Inc. Topical drug delivery system
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
WO2010044094A2 (en) 2008-09-03 2010-04-22 Krishna Radharaman Agarwal A topical composition for the treatment of erectile dysfunction
US20140227342A1 (en) 2013-02-08 2014-08-14 Michael Farber Acetylcholinesterase inhibitor composition for sexual use
AU2015249841B2 (en) * 2014-04-21 2020-05-14 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same
GB201609968D0 (en) * 2016-06-07 2016-07-20 Futura Medical Dev Ltd Topical pharmaceutical formulation
GB201713160D0 (en) * 2017-08-16 2017-09-27 Futura Medical Dev Ltd Topical composition
CN112423736A (zh) * 2018-06-01 2021-02-26 塔凡塔医疗匈牙利公司 用于治疗肛门直肠疾病的局部氨氯地平盐

Also Published As

Publication number Publication date
KR20220124712A (ko) 2022-09-14
PT3934624T (pt) 2024-04-23
CN115003278A (zh) 2022-09-02
MX2022007009A (es) 2022-08-25
EP4342494A3 (en) 2024-06-05
PL3934624T3 (pl) 2024-07-08
CA3160206A1 (en) 2021-06-17
FI3934624T3 (fi) 2024-05-24
EP4342494A2 (en) 2024-03-27
EP3934624B1 (en) 2024-03-13
WO2021116651A1 (en) 2021-06-17
ES2978421T3 (es) 2024-09-12
BR112022011284A2 (pt) 2022-09-06
EP3934624A1 (en) 2022-01-12
AU2020401440A1 (en) 2022-06-16
TW202135785A (zh) 2021-10-01
US20230022570A1 (en) 2023-01-26

Similar Documents

Publication Publication Date Title
DK4206298T3 (da) Stabiliserede fluorolefinsammensætninger og fremgangsmåde til fremstilling, oplagring og anvendelse deraf
DK4095193T3 (da) Dyppestøbesammensætning, fremgangsmåde til fremstilling af handske og handske
EP3922247A4 (en) 15-PGDH INHIBITOR
DK3553180T3 (da) Fremgangsmåde til konstruktion af enkeltcellesekventeringsbibliotek og anvendelse deraf
DK3285926T3 (da) Kit og fremgangsmåde til mikrobiologiske applikationer med høj kapacitet
DK3746446T3 (da) PRC2-inhibitorer
DK3606519T3 (da) ASK1-inhibitorforbindelser og anvendelser deraf
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
DE112020002266A5 (de) Kühlvorrichtung
DK3917626T3 (da) Psma-bindende dualmodusradiotracer og terapeutika
EP3776679A4 (en) MAGNETIC TUNNEL TRANSITIONS WITH ADJUSTABLE HIGH VERTICAL MAGNETIC ANISOTROPY
DK3607065T5 (da) Fremgangsmåde og kit til konstruktion af nukleinsyrebibliotek
EP3938721C0 (de) Kryostat
EP3999517A4 (en) CD73 INHIBITORS
DK3952003T3 (da) Anordning til visning af batterirestværdi
DK3892621T3 (da) Haloallylaminforbindelser og anvendelse deraf
DK3934624T3 (da) Topisk sammensætning og fremgangsmåder til måling af en topisk sammensætnings køleevne
DK3655121T3 (da) Multisportsareal til udøvelse af flere former for målsport og netsport
EP4001797A4 (en) SEMICONDUCTOR REFRIGERATION DEVICE
DK3930686T3 (da) Hidtil ukendt jernsammensætning og fremgangsmåder til fremstilling og anvendelse heraf
EP3967950A4 (en) REFRIGERATION DEVICE
DK3774751T3 (da) Co-krystaller
EP3985326A4 (en) Refrigeration device
EP3782632A4 (en) ANTI-STRESS COMPOSITION
EP4150272C0 (en) CRYOSTAT